Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin plus Doxorubicin vs Doxorubicin in Advanced Soft Tissue Sarcoma
NCT01104298Phase 2Terminated
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in soft tissue sarcoma (STS), sponsored by Spanish Group for Research on Sarcoma. Started Nov 2009; status: terminated.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01104298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104298.